Forgot user ID or password?
Don't have an account? Sign Up Now
FORUM 2025 JUNE 2 - 4
Congratualtions to our most recent Hall of Fame Inductee,Sherry Lee Gregory
The Canadian Pension & Benefits Institute (CPBI) is proud to announce the induction of four exceptional members into the CPBI Hall of Distinction for 2025.
Did you catch our February E-bulletin? Here it is again incase you missed it.
Did you catch our January E-bulletin? Here it is again incase you missed it.
Reformulary Group CEO and former Ontario ‘drug czar’ Helen Stevenson joins CPBI to talk about new and existing therapies that could overwhelm employer benefit plans – gene therapies, cancer drugs and diabetes treatment. Would it surprise you to know that a gene therapy costing more than $2.8 million per patient has recently been approved in Canada, or that some private plans are paying claims for cancer drugs that are typically covered by cancer agencies? As more and more expensive drugs roar up the regulatory pipeline, understanding their cost and how plans can be informed and manage their impact has never been more important.
SPEAKER
Helen Stevenson, B.Comm., M.Sc., ICD.D,Founder and CEO - Reformulary Group Inc.
Are you attending several sessions? It may be worth it to renew or to get a membership.
Comments? Questions? Email us! CPBI Pacific Region [email protected]
REGISTRATION FEES
Cancellations will be accepted 3 business days before the session. Non-attendees or cancellations received after this time will not be reimbursed.